Crohn S Diseases
Mostrando 1-12 de 13 artigos, teses e dissertações.
-
1. Religious coping and its influence on psychological distress, medication adherence, and quality of life in inflammatory bowel disease
Objective:Inflammatory bowel disease (IBD) is associated with elevated levels of anxiety and depression and a reduction in health-related quality of life (HRQoL). Nonadherence to treatment is also frequent in IBD and compromises outcomes. Religious coping plays a role in the adaptation to several chronic diseases. However, the influence of religious coping o
Rev. Bras. Psiquiatr.. Publicado em: 2015-09
-
2. Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro
OBJECTIVES: Conflicting data from studies on the potential role of multidrug resistance 1 gene polymorphisms in inflammatory bowel disease may result from the analysis of genetically and geographically distinct populations. Here, we investigated whether multidrug resistance 1 gene polymorphisms are associated with inflammatory bowel diseases in patients fro
Clinics. Publicado em: 2014
-
3. Assessment of clinical and nutritional parameters with the use of probiotics Lactobacillus casei and Bifidobacterium breve in Crohn s disease / Avaliação de parametros clinicos e nutricionais com emprego dos probioticos Lactobacillus casei e Bifidobacterium breve portadores de Doença de Crohn
Patients with Crohn s disease (CD) frequently present diarrhea and malnutrition, which is hard to treat and influenced by the disease activity, location and extension of intestinal involvement. The application of probiotics on intestinal inflammatory diseases can be useful because of its effects on intestinal microbiota, with potential anti-inflammatory and
Publicado em: 2009
-
4. The use of stem cells for the treatment of autoimmune diseases
Autoimmune diseases constitute a heterogeneous group of conditions commonly treated with anti-inflammatory, immunosuppressant and immunomodulating drugs, with satisfactory results in most cases. Nevertheless, some patients become resistant to conventional therapy. The use of high doses of drugs in such cases results in the need for bone marrow reconstitution
Brazilian Journal of Medical and Biological Research. Publicado em: 29/10/2007
-
5. Plastias de estenoses jejunais, ileais e ileocecais na doença de Crohn : analise de resultados imediatos e tardios / Jejunal, ileal and ileocecal strictureplasty as the surgical treatment of Crohn s disease
Strictureplasty is an altemative surgical procedure for Crohn s disease, particulary in patients with previous resections or many intestinal stenosis. The aim of this tudy was to analyze surgical complications and clinical follow-up in patients submitted to strictureplasty secondary to Crohn s disease. Twenty-eight patients (57,1% male, mean age 33,3 years,
Publicado em: 2005
-
6. Avaliação da atividade de eosinofilos perifericos em pacientes com doenças inflamatorias intestinais
Eosinophils are involved in the pathogenesis of several chronic inflammatory diseases, including inflammatory bowel disease (ffiD), as Crohn s disease (CD) and ulcerative colites (DC). However, how activation of intravascular eosinophils contributes to disease activity or ffiD pathogenesis is still unknown. The aim of this study was to investigate if eosinop
Publicado em: 2004
-
7. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases
The human MHC represents the strongest susceptibility locus for autoimmune diseases. However, the identification of the true predisposing gene(s) has been handicapped by the strong linkage disequilibrium across the region. Furthermore, most studies to date have been limited to the examination of a subset of the HLA and non-HLA genes with a marker density and
National Academy of Sciences.
-
8. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.
Patients with idiopathic ulcerative colitis (UC) have a colonbound antibody (CCA-IgG) that reacts with colon tissue extracts. We have partially characterized a colonic protein that is specifically recognized by CCA-IgG. CCA-IgG was eluted from operative colon specimens from 10 patients with UC. A colon tissue-bound IgG was similarly eluted from six patients
-
9. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis.
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) of unknown aetiology which are characterised by chronic inflammation of the gastrointestinal tract. Epidemiological studies suggest the presence of a genetic component in the aetiology of both CD and UC. A susceptibility gene for Crohn's disease has recently been mapped to
-
10. Antibody-mediated leucocyte cytotoxicity to Chang human liver cells in rheumatoid arthritis and other diseases.
The incidence of an IgG-antibody which induces lymphocyte cytotoxicity to Chang human liver cells in culture was estimated in the sera of patients with rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and in healthy controls. It was found in 4.1% of control subjects and in 3
-
11. TNF-αneutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis
Tumor necrosis factor α (TNF-α) is an important mediator of programmed cell death, and TNF-α blockade significantly improves disease severity in several inflammatory conditions, including Crohn's disease (CD), one of the idiopathic inflammatory bowel diseases. However, the precise mechanism(s) of action of anti-TNF-α therapy in CD remains poorly und
National Academy of Sciences.
-
12. Validation and standardization of Kveim test suspensions prepared from two human sarcoid spleens.
Single lots of a Chase-Siltzbach type I Kveim test material from each of two sarcoid spleens and designated lot 5 of spleen K12 and lot 1 of spleen K13 have been validated alongside a single lot (lot 10) of a 'standard' suspension provided by Dr L. E. Siltzbach and prepared identically from the spleen of patient J (SPLEEN J) in New York. Additionally, a half